| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/01/1999 | EP0938578A1 Genetic modification of primate hemopoietic repopulating stem cells |
| 09/01/1999 | EP0938567A1 Applications for regulatory region of nos isoforms |
| 09/01/1999 | EP0938563A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
| 09/01/1999 | EP0938560A1 GENOMIC NUCLEIC ACIDS, cDNA AND mRNA WHICH CODE FOR POLYPEPTIDES WITH IL-16 ACTIVITY, PROCESSES FOR THE PRODUCTION THEREOF AND THEIR USE |
| 09/01/1999 | EP0938559A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR |
| 09/01/1999 | EP0938558A2 Gaba a receptor subunit epsilon-related protein |
| 09/01/1999 | EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/01/1999 | EP0938556A1 Gamma-heregulin |
| 09/01/1999 | EP0938554A1 Human protein kinase c inhibitor homolog |
| 09/01/1999 | EP0938548A1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
| 09/01/1999 | EP0938547A1 Modified ligands of calcium-dependent binding proteins |
| 09/01/1999 | EP0938506A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 09/01/1999 | EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 09/01/1999 | EP0938504A2 Ob PROTEIN BINDING PROTEIN |
| 09/01/1999 | EP0938503A1 Insulin c-peptides |
| 09/01/1999 | EP0938502A1 Selective acylation method |
| 09/01/1999 | EP0938500A1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/01/1999 | EP0938499A1 Analogs of cationic proteins |
| 09/01/1999 | EP0938498A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 09/01/1999 | EP0938497A1 Constrained helical peptides and methods of making same |
| 09/01/1999 | EP0938496A1 Heptapeptide oxytocin analogues |
| 09/01/1999 | EP0938495A1 Compounds which prevent neuronal cell death and uses thereof |
| 09/01/1999 | EP0938494A1 Inhibitors of protein farnesyl transferase |
| 09/01/1999 | EP0938493A1 Method of isolating cyclosporins |
| 09/01/1999 | EP0938341A2 Compositions and methods for altering the biodistribution of biological agents |
| 09/01/1999 | EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof |
| 09/01/1999 | EP0938334A1 Improved method of treating immune cell mediated systemic diseases |
| 09/01/1999 | EP0938333A1 Method of enhancing the delivery of growth factors |
| 09/01/1999 | EP0938332A1 Use of delta-like protein to inhibit the differentiation of stem cells |
| 09/01/1999 | EP0938331A1 Therapeutic uses of bpi protein products in cystic fibrosis patients |
| 09/01/1999 | EP0938330A1 Use of lh-rh antagonists as diagnostic agent |
| 09/01/1999 | EP0938329A1 Immunogenic tlp composition |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938326A1 Synthetic phosphopeptides for treating bone diseases |
| 09/01/1999 | EP0938303A1 Antioxidant-induced apoptosis in vascular smooth muscle cells |
| 09/01/1999 | EP0938297A1 Immunomodulatory formulation |
| 09/01/1999 | EP0760681B1 Modification of clostridial toxins for use as transport proteins |
| 09/01/1999 | EP0752882A4 Treatment for juvenile diabetes |
| 09/01/1999 | EP0723455A4 Methods of inhibiting phagocytosis |
| 09/01/1999 | EP0706382B1 Therapeutic preparation for inhalation |
| 09/01/1999 | EP0701616B1 Multicistronic expression of recombinant genes in bacterial cells |
| 09/01/1999 | EP0700301B1 Peptides and compounds that bind to elam-1 |
| 09/01/1999 | EP0672055B1 Neuropeptide y antagonists |
| 09/01/1999 | EP0652951B1 GDF-1and UOG-1 proteins |
| 09/01/1999 | EP0643780B2 Multiple solvent cleaning system |
| 09/01/1999 | EP0625160B1 Leukinferon preparation |
| 09/01/1999 | EP0573545B1 Monoclonal antibodies against receptor-induced binding sites |
| 09/01/1999 | CN1227610A Antibodies against a complex of CD4 and a chemokine receptor domain, and their use against HIV infections |
| 09/01/1999 | CN1227607A Humanized immunoglobulin reactive with alpha 4 beta 7 integrin |
| 09/01/1999 | CN1227604A Multivarient IL-3 hematopoiesis fusion protein |
| 09/01/1999 | CN1227603A TIE-2 receptor ligands (TIE ligand-3; TIE ligand-4) and their uses |
| 09/01/1999 | CN1227602A Tumor antigen proteins, genes thereof and tumor antigen peptides |
| 09/01/1999 | CN1227567A Exendin analogues, processes for their preparation and medicaments containing them |
| 09/01/1999 | CN1227566A T cell epitope peptide |
| 09/01/1999 | CN1227565A Viral peptides with structural homology to protein G of respiratory syncytial virus |
| 09/01/1999 | CN1227501A Long-acting drugs and pharmaceutical compositions comprising them |
| 09/01/1999 | CN1227496A Screening method for compounds useful in the regulation of body weight |
| 09/01/1999 | CN1227495A Compositions of plant carbohydrates as dietary supplements |
| 09/01/1999 | CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell |
| 09/01/1999 | CN1227125A Compound beta interferon lozenge and its preparing method |
| 09/01/1999 | CN1227124A Beta interferon lozenge and its preparing method |
| 08/31/1999 | USRE36288 Mixture of protein, lipid and carbohydrates |
| 08/31/1999 | US5945522 A nucleic acid that codes a pg1 gene; diagnosing prostate cancer and screening for mutation in gene |
| 08/31/1999 | US5945514 Mannose binding lectin bonded through hydrophylic high molecular weight chain to hydrophobic molecular weight chain; aerosols, creams, lotions for prophylactic use against human immunodeficiency viruses and others |
| 08/31/1999 | US5945513 A human t-cell antigen and ligand for cd40 receptor; for promoting b cell proliferation, immunosuppressant for transplants, therapy for autoimmune diseases, human immunodeficiency virus and antitumor agents |
| 08/31/1999 | US5945510 Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| 08/31/1999 | US5945508 Administering aerosolized mutant substance p as antimetastasis agent |
| 08/31/1999 | US5945507 An amino acid sequence that codes for a viral transmembrane protein; microbiocides, bactericides, fungicides, viricides and antiprotozoa agents |
| 08/31/1999 | US5945505 Human phospholemman-like protein |
| 08/31/1999 | US5945452 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 08/31/1999 | US5945448 Brain edema inhibitor |
| 08/31/1999 | US5945446 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 08/31/1999 | US5945432 Thrombolytic agents and thienopyridine derivatives in acute stroke |
| 08/31/1999 | US5945403 Angiostatin fragments and method of use |
| 08/31/1999 | US5945402 Human relaxin formulation |
| 08/31/1999 | US5945401 Polypeptides as antidiabetic agents |
| 08/31/1999 | US5945400 Nucleic acid-containing composition, preparation and use thereof |
| 08/31/1999 | US5945399 Administering to provide alleviation of adverse efects of or complications associated with the disease including mortality and complications or morbidities |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945397 A soluble protein capable binding tumor necrosis factor for use in raising antibodies, in diagnosis and therapy, regulating the immune activities of cytokine |
| 08/31/1999 | US5945336 Oligonucleotide up to 35 nucleotides in length with at least 18 contiguous nucleotides complementary to specific nucleotide sequence; for suppression of interleukin-6 receptors; anticarcinogenic agents; viricides |
| 08/31/1999 | US5945330 Polynucleotide |
| 08/31/1999 | US5945316 From optically active or racemic amino acids and 2-hydroxycarboxylic acids |
| 08/31/1999 | US5945315 Isolating compound from culture of gsv224 nostoc species; antiproliferative agent for drug resistant cells |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945308 Polynucleotide |
| 08/31/1999 | US5945307 Nucleotide sequences that code a protein expressed in the brain and belonging to the 5-hydroxytryptamine receptor family; gene therapy, screening of drugs and genetic disorders, diagnostic assays |
| 08/31/1999 | US5945306 Polynucleotides |
| 08/31/1999 | US5945305 Polynucleotides for diagnosing congenital heart disease resulting from down syndrome |
| 08/31/1999 | US5945303 Isolated nucleic acid encoding human humatopoietic-specific protein for use in treating autoimmune disorder, graft rejection, antitumor agent, viral infection, fungal and bacteria infection |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/31/1999 | US5945300 Polypeptides with dna(rna) encoding and genetic engineering |
| 08/31/1999 | US5945275 Nematode-extracted anticoagulant protein |
| 08/31/1999 | US5945274 Quantitative analysis of free lysylpyridinoline in a urine sample and correlating it to bone resorption in vivo wherein urine sample is hydrolyzed |
| 08/31/1999 | US5945273 Human oxalyl-coa decarboxylase |
| 08/31/1999 | US5945272 Autoclavable mixture of subphysiological concentrations of potassium, magnesium, sodium, calcium and chloride ions; water soluble oncotic agents; carboxylic acids or salts; and blood clotting factors; free of biological buffers |
| 08/31/1999 | US5945128 Process to manufacture implants containing bioactive peptides |
| 08/31/1999 | US5945105 Peptides of the antigen Sm-D and their use, in particular for the diagnostics of systemic lupus erythematosus (SLE) |
| 08/31/1999 | US5945104 A peptide carrier conjugate where carrier is selected from tetanus-texoid and purified protein derivative of tuberculin |
| 08/31/1999 | US5945103 Process for producing thrombin |